Shiyu Han
Overview
Explore the profile of Shiyu Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu S, Liu M, Han S, Zhu J, Deng X, Tian Y, et al.
J Pharm Biomed Anal
. 2025 Jan;
257:116679.
PMID: 39864142
Background: The incidence of Parkinson's disease (PD) increases with age. Previous pharmacological studies have shown the potential of Huatan Jieyu Granules (HGs) for the treatment of PD, but the exact...
2.
Zhao G, Fang M, Han S, Peng X, Dong A
Front Neurol
. 2024 Dec;
15:1511767.
PMID: 39669104
Background: Repetitive transcranial magnetic stimulation (rTMS) and median nerve electrical stimulation (MNES) are two non-invasive neuromodulation techniques that have demonstrated potential in facilitating the recovery of consciousness in patients with...
3.
Yi F, Wang J, Lin M, Li B, Han S, Wang S, et al.
Front Aging Neurosci
. 2024 Oct;
16:1429098.
PMID: 39351014
Objective: White matter hyperintensities (WMH) are the most common neuroimaging manifestation of cerebral small vessel disease, and is frequently observed in Alzheimer's disease (AD). This study aimed to investigate the...
4.
Hua W, Qi J, Zhou M, Han S, Xu X, Su J, et al.
Ann Hematol
. 2024 Jul;
103(9):3563-3572.
PMID: 39012516
Acute myeloid leukemia (AML) is a notably lethal disease, characterized by malignant clonal proliferation of hematopoietic stem cells in the bone marrow. This study seeks to unveil potential therapeutic targets...
5.
Mao G, Li J, Wang N, Yu H, Han S, Xiang M, et al.
Front Oncol
. 2024 Jun;
14:1392417.
PMID: 38894865
Background: Squamous cell carcinoma of the lung (LUSC) is a severe and highly lethal malignant tumor of the respiratory system, and its molecular mechanisms at the molecular level remain unc\lear....
6.
Li B, Wang S, Han S, Hu N, Shang X
Front Neurol
. 2023 Aug;
14:1227566.
PMID: 37533465
Background: Obsessive-compulsive disorder (OCD) is a common reason for patients to seek symptomatic treatment in psychiatric departments, which makes it challenging to consider underlying organic nervous system diseases. However, Creutzfeldt-Jakob...
7.
Wang S, Wang J, Li B, Hu N, Jin Y, Han S, et al.
Front Immunol
. 2023 Jun;
14:1191823.
PMID: 37304289
Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is the second most common kind of autoimmune encephalitis following anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. Anti-LGI1 encephalitis is characterized by cognitive impairment or rapid progressive dementia,...
8.
Yang J, Xu X, Han S, Qi J, Li X, Pan T, et al.
Ann Hematol
. 2022 Dec;
102(1):31-39.
PMID: 36547721
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA) is a fatal post-transplant complication. It has a high mortality rate and worse prognosis, but treatment strategies remain controversial. We screened 6 out...
9.
Wang M, Zhu Z, Kan Y, Yu M, Guo W, Ju M, et al.
Mol Cell Endocrinol
. 2022 Jun;
552:111688.
PMID: 35654225
It was reported that spexin as an adipocyte-secreted protein could regulate obesity and insulin resistance. However, the specific metabolic contribution of spexin to fatty liver remains incompletely understood. Herein, we...
10.
Pan T, Han S, Zhou M, Qi J, Wang H, Xu X, et al.
Expert Rev Hematol
. 2022 May;
15(5):457-464.
PMID: 35535679
Background: Relapse is the leading cause of death from myeloid malignancies after allogeneic hematopoietic stem cell transplantation (HSCT). Azacitidine has gained attention in recent years in the prophylaxis of relapsed...